Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. AbbVie Inc.
  6. News
  7. Summary
    ABBV   US00287Y1091

ABBVIE INC.

(ABBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AbbVie : Daiwa Securities Starts AbbVie at Outperform With $126 Price Target

07/02/2021 | 07:12am EDT


ę MT Newswires 2021
All news about ABBVIE INC.
09/23ABBVIE : Presents New Data Analyses for Growing Dermatology Portfolio at the 30th European..
PR
09/22ABBVIE : N.D. Ill. Finds That A Foreign Parent Corp. May Be Sued Under BPCIA Without The U..
AQ
09/21INCYTE : FDA approves Incyte's eczema cream with boxed warnings
RE
09/20ABBVIE : Seeks FDA Approval for Crohn's Disease Treatment Candidate
MT
09/20ABBVIE : Submits Regulatory Application to FDA for Risankizumab-rzaa (SKYRIZI«) for the Tr..
PR
09/20AbbVie Submits Regulatory Application to FDA for Risankizumab-rzaa (SKYRIZI«) for the T..
CI
09/16ABBVIE : Files Regulatory Applications in US and Europe for Upadacitinib to Treat Adults W..
MT
09/16ABBVIE : Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ«) for the..
PR
09/16AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib for the Treatmen..
CI
09/16AbbVie Submits Regulatory Applications for Treatment of Ulcerative Colitis
DJ
More news
Analyst Recommendations on ABBVIE INC.
More recommendations
Financials (USD)
Sales 2021 56 247 M - -
Net income 2021 12 652 M - -
Net Debt 2021 66 393 M - -
P/E ratio 2021 14,6x
Yield 2021 4,79%
Capitalization 189 B 189 B -
EV / Sales 2021 4,54x
EV / Sales 2022 4,07x
Nbr of Employees 48 000
Free-Float 98,0%
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | ABBV | US00287Y1091 | MarketScreener
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 107,07 $
Average target price 125,48 $
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman-Management Board & President
Robert A. Michael Chief Financial Officer & Executive Vice President
Thomas J. Hudson Chief Scientific Officer, Senior VP-R&D
Azita Saleki-Gerhardt Executive Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
ABBVIE INC.-0.07%189 211
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.19.37%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037